This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.


HIV-Associated Cardiovascular Disease

Edited by Edited by Guiseppe Ippolito and Nicola Petrosillo (Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani, Rome, Italy), Giuseppe Barbaro (University of Rome), and Steven Lipshultz (University of Rochester Medical Center, Rochester, NY)
HIV-Associated Cardiovascular Disease

Published: November 2001

Volume 946

Learn More

International specialists examine therapeutic choices for the treatment of myocardial cell dysfunction in HIV disease, with a focus on the most recent knowledge in both clinical and biological aspects of HIV-associated cardiovascular disease. Topics covered include research findings from experimental work on transgenic mice; the role of cytokines in the development of HIV-associated cardiomyopathy and pulmonary hypertension (with related diagnostic and therapeutic implications); and the relationship between dilated cardiomyopathy and encephalopathy in HIV-infected adults and children. The detrimental cardiovascular effects of drugs such as reverse transcriptase inhibitors and protease inhibitors, which have significantly changed the natural history of HIV disease, are also discussed.

This volume is out of print.